Role of Caspases and Mitochondria in the Steroid-Induced Programmed Cell Death of a Motoneuron during Metamorphosis  by Hoffman, Kurt L. & Weeks, Janis C.
Developmental Biology 229, 517–536 (2001)
doi:10.1006/dbio.2000.9987, available online at http://www.idealibrary.com onRole of Caspases and Mitochondria in the
Steroid-Induced Programmed Cell Death of a
Motoneuron during Metamorphosis
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Accessory planta retractor (APR) motoneurons of the hawk moth, Manduca sexta, undergo a segment-specific pattern of
programmed cell death (PCD) 24 to 48 h after pupal ecdysis (PE). Cell culture experiments show that the PCD of APRs in
abdominal segment 6 [APR(6)s] is a cell-autonomous response to the steroid hormone 20-hydroxyecdysone (20E) and
involves mitochondrial demise and cell shrinkage. Twenty-four hours before PE, at stage W3-noon, APR(6)s require further
20E exposure and protein synthesis (as tested with cycloheximide) to undergo PCD, and death can be blocked by a
broad-spectrum caspase inhibitor. By PE, death is 20E- and protein synthesis-independent and the caspase inhibitor blocks
cell shrinkage but not loss of mitochondrial function. Thus, the commitment to mitochondrial demise precedes the
commitment to execution events. The phenotype of necrotic cell death induced by a mitochondrial electron transfer
inhibitor differs unambiguously from 20E-induced PCD. By inducing PCD pharmacologically, the readiness of APR(6)s to
execute PCD was found to increase during the final larval instar. These data suggest that the 20E-induced PCD of APR(6)s
includes a premitochondrial phase which includes 20E-induced synthetic events and apical caspase activity, a mitochon-
drial phase which culminates in loss of mitochondrial function, and a postmitochondrial phase during which effector
caspases are activated and APR(6) is destroyed. © 2000 Academic Press
Key Words: apoptosis; autophagy; caspase; ecdysteroid; insect; metamorphosis; mitochondria; motoneuron; programmed
cell death; steroid hormone.h
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1INTRODUCTION
During development, programmed cell death (PCD)—
intentional cellular suicide—eliminates damaged, out-
moded, or excess cells. Precise spatial and temporal execu-
tion of PCD in the nervous system is essential for the
correct development of neural circuits and behavior. Stud-
ies in intact organisms, cell culture, and cell-free systems
have identified genes and proteins involved in PCD, many
of which exhibit remarkable evolutionary conservation
(reviewed by Aravind et al., 1999; Liu and Hengartner,
1999). Progress has been especially rapid in genetically
tractable organisms such as the nematode Caenorhabditis
elegans and the fruit fly Drosophila melanogaster (reviewed
by Bergmann et al., 1998; Abrams, 1999). Factors that
influence whether particular neurons die or survive include
the levels of, and developmental timing of exposure to,
1 Current address: Emerging Diseases Laboratory, Gillespie Neu-
roscience Research Facility, Department of Neurology, Universitynof California at Irvine, Irvine, CA 92697.
0012-1606/00 $35.00
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All rights of reproduction in any form reserved.ormones and neurotrophic factors, which must be coordi-
ated with the expression of appropriate receptors (re-
iewed by Burek and Oppenheim, 1996). However, with few
xceptions [e.g., the dependence of sympathetic neurons on
erve growth factor (NGF); Vogel, 1993; Deshmukh and
ohnson, 1997], the specific identity of the extrinsic sig-
al(s) that determines whether a particular neuron lives or
ies is unknown. A major challenge is to identify the
iologically relevant signals that determine neuronal death
r survival and to determine how these signals are trans-
uced and integrated intracellularly to produce develop-
entally appropriate PCD.
Hormones that act via members of the nuclear hormone
eceptor superfamily (e.g., gonadal steroid hormones, glu-
ocorticoids, thyroid hormone, and insect ecdysteroids) can
ave profound effects on neuronal growth and survival.
uclear receptors are intracellular ligand-gated transcrip-
ion factors that regulate gene transcription (Beato et al.,
996). The effects of steroid hormones on the developing
ervous systems of insects and vertebrate animals are
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518 Hoffman and Weekssimilar (reviewed by Weeks and Levine, 1995; Weeks and
McEwen, 1997). During insect metamorphosis, a class of
steroid hormones, the ecdysteroids, regulates neuronal sur-
vival, dendritic and axonal growth or regression, synaptic
remodeling, and other changes in neuronal phenotype. In
amphibians, metamorphic changes are regulated by thyroid
hormone (Hoskins and Grobstein, 1984; Tata, 1994). In
avian and mammalian species, gonadal steroid hormones
generate sexually dimorphic regions of the nervous system
through sex- and region-specific regulation of neuronal
birth, growth, and survival (reviewed by Garcı´a-Segura et
al., 1994; Kawata, 1995). In most cases it is unknown
whether an effect is mediated by a direct action on the
neurons of interest or by indirect signals from other hor-
monally sensitive cells (or a combination of the two ef-
fects). This information is crucial in understanding how
PCD is activated or repressed within individual neurons.
We study the steroid regulation of neuronal PCD in an
individually identified motoneuron, the accessory planta
retractor (APR), in the hawk moth, Manduca sexta. APRs
re present in larval abdominal segments 1 through 6
A1–A6) and are designated by segmental location [i.e.,
PR(1), APR(2), etc.]. APRs innervate accessory planta
FIG. 1. Endocrine events during Manduca metamorphosis. The tim
(solid line) and juvenile hormone (dashed line) from the fourth larva
1981; Riddiford and Truman, 1994). Developmental days and sta
abbreviations below). The occurrence of each ecdysis is indicated b
A3–A6 labeled and midbody larval prolegs indicated by arrows. AP
fourth larval instar and placed in culture at the following times (ver
ecdysis (PE). In vivo, all APR(6)s are alive on day P0 and all are dead
tage; CP, commitment pulse of ecdysteroids; LE, ecdysis to the fif
upal ecdysis (which occurs on day P0); P1, P2, etc., days after P0; P
eaves the food to burrow underground); W1, W2, etc., days after wetractor muscles (APRMs). In A3 through A6, which bear
Copyright © 2000 by Academic Press. All rightrolegs (locomotory appendages; see Fig. 1), the APRMs
unction as proleg retractor muscles, whereas in A1 and A2,
hich do not bear prolegs, the APRMs are unspecialized
ody wall muscles (Weeks and Ernst-Utzschneider, 1989;
andstrom and Weeks, 1996). The prolegs degenerate during
he larval–pupal transformation and, depending on segmen-
al location, individual APRs and their target muscles
ither undergo PCD (A1, A5, and A6) or are respecified for
ew functions in the pupa (A2, A3, and A4). In A2 and A3,
PRs and APRMs are respecified to circulate hemolymph
ithin the developing adult wings and legs (Sandstrom and
eeks, 1998; Lubischer et al., 1999), while in A4, the
PRMs degenerate and the APRs innervate a new abdomi-
al extensor muscle that develops during the pupal stage
Weeks and Ernst-Utzschneider, 1989; Sandstrom and
eeks, 1998). The APRs that survive through the pupal
tage degenerate along with their target muscles after adult
mergence. Much is known about the role of APRs in
eural circuits for larval and pupal behaviors (Streichert and
eeks, 1995; Sandstrom and Weeks, 1991, 1998; Lubischer
t al., 1999; reviewed by Weeks et al., 1997), so the
unctional context for their segment-specific deaths is well
nderstood.
ne illustrates changes in relative hemolymph levels of ecdysteroids
tar to adulthood (hormone titers redrawn from Bollenbacher et al.,
elevant to this study are indicated along the horizontal axis (see
ertical dotted line. Bottom drawings show insects with segments
were labeled by injecting DiI into their target muscles during the
arrows): larval day 2 (L2), day W3 at 12:00 (stage W3-noon), or pupal
ay P2 (Weeks et al., 1992). Abbreviations: AE, ecdysis to the adult
val instar (which occurs on day L0); L1, L2, etc., days after L0; PE,
epupal peak of ecdysteroids; W0, day of wandering (when the larva
ering.e li
l ins
ges r
y a v
R(6)s
tical
on d
th lar
P, prThe same hormones that control the insect molt cycle
s of reproduction in any form reserved.
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519Programmed Cell Death of a Motoneuronregulate neurodevelopmental events. During metamorpho-
sis, each molt is triggered by a surge in the hemolymph
(blood) levels of ecdysteroids, with the type of molt deter-
mined by the level of juvenile hormone (JH; reviewed by
Nijhout, 1994; see Fig. 1). An ecdysteroid rise in the
presence of JH triggers larval–larval molts. During the final
larval instar (stage) of Manduca, the JH titer drops and a
mall pulse of ecdysteroids on day L3 (the commitment
ulse) reprograms cells to a pupally committed state (e.g.,
eeks and Truman, 1986). The commitment pulse also
riggers wandering behavior, when the larva burrows under-
round to pupate. The prepupal peak of ecdysteroids then
riggers the molt to the pupal form, culminating in pupal
cdysis (PE) when the final larval cuticle is shed. Develop-
ent of the adult moth is driven by a prolonged elevation of
cdysteroids in the absence of JH. Hormonal extirpation
nd replacement experiments in vivo show that the prepu-
al peak of 20-hydroxyecdysone (20E) triggers the PCD of
PRs at pupation, whereas the fall of 20E at the end of
upal life triggers the PCD of APRs at adult emergence
Weeks et al., 1992; Zee and Weeks, 1998; and in prepara-
ion). Manipulations of the target muscles, sensory inner-
ation, and interganglionic inputs of APRs fail to demon-
trate a role for cellular interactions in regulating the
egmental pattern of death (Weeks and Davidson, 1994;
ubischer and Weeks, 1996), suggesting that the response to
0E might be direct. This possibility was confirmed by the
nding that, when APRs are removed from the nervous
ystem and placed in cell culture, they continue to express
he correct segment-specific pattern of PCD in response to
hysiological levels of 20E (Streichert et al., 1997; Hoffman
and Weeks, 1998a; Zee and Weeks, 1998; and in prepara-
tion). APRs exhibit nuclear immunoreactivity for ecdy-
steroid receptors (EcRs) during the prepupal peak of 20E (J.
Ewer, G. Kinch, and J. C. Weeks, unpublished observations).
APRs thus possess intrinsic segmental identities that
regulate, cell autonomously, whether a particular 20E sig-
nal triggers PCD. This provides an ideal system in which to
investigate the mechanisms by which a normal biological
cue—a change in the circulating level of a steroid
hormone—directly regulates PCD within a particular neu-
ron. The large size of APRs (cell body dimensions of ;50 3
0 mm in larvae) further enhances their utility. Mechanistic
tudies have focused on APR(6)s, which are representative
f APRs that die at pupation. Hoffman and Weeks (1998a)
ested the effects of 20E and the protein synthesis inhibitor
ycloheximide (CHX) on the survival of APR(6)s cultured at
wo different developmental times: stage PE, or 24 h prior to
E, at stage W3-noon (see Materials and Methods for
taging). These experiments showed that, at stage W3-noon,
PR(6)s require both further exposure to 20E and further
rotein synthesis to undergo 20E-induced PCD. One day
ater, at PE, the death of a substantial subset of APR(6)s has
ecome both 20E- and protein synthesis-independent, and
xecution events (e.g., loss of mitochondrial function and
ell body shrinkage) transpire over the next 24 h. Thus,
Copyright © 2000 by Academic Press. All rightynthetic events during the final 24 h of larval life are
ssential for APR(6)s to carry out 20E-induced PCD.
The goal of the present study was to further examine
ellular mechanisms of PCD in APR(6)s, in particular the
nvolvement of caspases (a class of cysteine proteases
idely implicated in PCD; reviewed by Thornberry and
azebnik, 1998) and mitochondria (which are critical con-
rol points in PCD signaling; reviewed by Susin et al., 1998).
ur results support a working model for the 20E-induced
CR of APR(6)s that includes: (1) a premitochondrial phase
hich includes 20E-induced synthetic events and activa-
ion of apical caspases, (2) a mitochondrial phase which
ommits mitochondria to their demise and culminates in
oss of mitochondrial function, and (3) a postmitochondrial
hase which includes the activation of effector caspases and
tructural destruction of the neuron. Some results were
eported previously in an abstract (Hoffman and Weeks,
998b).
METHODS
Animals and Staging
M. sexta larvae were reared individually in cups containing
artificial diet (modified from Bell and Joachim, 1976) in an incuba-
tor with a 17:7 h light/dark photoperiod (lights off at 00:00) and
27:25°C thermoperiod. Insects were staged as follows (Fig. 1): day
L2 was the second day after ecdysis (cuticle shedding) to the fifth
larval instar; day W0 was the day of onset of wandering behavior;
days W1, W2, and W3 were the first, second, and third days after
day W0, respectively; day P0 was the day on which pupal ecdysis
(the shedding of the final larval cuticle) occurred. Insects were
selected on day L2 between 9:00 and 17:00 or on day W3 at 12:00
(designated stage W3-noon; Hoffman and Weeks, 1998a). Pupal
ecdysis typically occurred between 06:00 and 12:00 on day P0.
Pupae selected up to 50 min after the completion of pupal ecdysis
were designated stage PE. Insects at the desired stages were held at
2°C for up to 24 h to arrest development, prior to dissection.
Identification and Culture of APR(6)s
Techniques were similar to those used previously to culture
APRs (Streichert et al., 1997; Hoffman and Weeks, 1998a). APRs
were labeled in vivo by injecting ;5 ml of a suspension of DiI
Molecular Probes; 10 mg/ml in petroleum jelly) adjacent to both
PRMs in segment A6 of mid-fourth-instar larvae. Two APRs
nnervate each APRM (Sandstrom and Weeks, 1996), so up to four
PRs were labeled in ganglion A6. Following DiI injection, insects
ere allowed to develop to the desired stage. After anesthetization
y chilling at 2°C, ganglion A6 was removed and placed in basal
ulture medium (see below) and desheathed on the ventral surface.
he anterior, ventral portion of the ganglion, containing APR cell
odies, was removed with tungsten dissecting needles and trans-
erred to an enzyme solution (see below) in a glass well of a plastic
5-mm petri dish; wells were formed by affixing a glass coverslip
eneath a hole made in the bottom of the dish. The enzyme
olution contained collagenase (1 mg/ml; Sigma Type XI) and
ispase (4 mg/ml; Boerhinger Mannheim Grade II) in Ca21-free,
Mg21-free Hanks’ balanced salt solution. After incubation at room
temperature for 2–4 min, the tissue was transferred to a well
s of reproduction in any form reserved.
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520 Hoffman and Weekscontaining basal medium and mechanically dissociated into single
cells using finely pulled capillary glass. APR(6)s, identified by their
DiI label viewed under epifluorescence optics, were transferred
individually to wells containing ;150–300 ml of control or experi-
mental culture medium (see below). In vivo, APRs are unipolar,
with a large primary neurite from which the axon and dendrites
arise (e.g., Weeks and Truman, 1984); when placed in culture, APRs
lacked processes except, in some cases, for a short stump of the
primary neurite. One to six APR(6)s with normal, healthy appear-
ance (e.g., large, ovoid, phase-bright somata) were placed in each
dish. For 24-h cultures, APRs were placed on uncoated glass. For
10-day cultures, dishes were coated with laminin and concanavalin
A (Prugh et al., 1992). Cultures were maintained in a humidified
incubator at 26°C in ambient air. APR(6)s were cultured at suffi-
ciently low density that few contacted each other, and this oc-
curred only in long-term cultures. As reported previously
(Streichert et al., 1997; Hoffman and Weeks, 1998a), contact had no
apparent effect on any results reported here.
Culture Media
The culture medium was supplemented L15 (Gibco), with no
fetal bovine serum added (Prugh et al., 1992). It was filter-sterilized
before use. Basal culture medium, used during dissociation and
staining procedures, did not contain antibiotics. Control culture
medium was basal medium containing 100 U/ml penicillin and
100 mg/ml streptomycin (Gibco). Experimental culture medium
was control culture medium containing 20E (Sigma; 1.0 mg/ml),
henoyltrifluoroacetone (TTFA) (Sigma; 1.0 mM, in 1% EtOH),
HX (Sigma; 10 mg/ml), actinomycin D (ActD) (Sigma, 100 ng/ml),
or benzyloxycarbonyl-aspartate-2,6-dichlorobenzoyloxymethyl ke-
tone (Z-Asp-CH2DCB) (Bachem; 0.2–20 mM). In experiments in
which the two media being compared each contained a drug or 20E
(Figs. 4 and 7), one medium was designated the control and the
other the experimental. When using 20E, CHX, ActD, or Z-Asp-
CH2DCB, APR(6)s dissociated at the same time were plated into
arallel control and experimental cultures. Two or more APR(6)s
btained from a single ganglion were distributed between the two
onditions. For long-term cultures, approximately half the medium
as replaced every third day with fresh medium of the same
omposition.
Scoring of APR(6) Phenotype
Depending on the experiment, APR(6)s were cultured for 24 h or
10 days. For 24-h experiments, only APR(6)s that had normal
morphology when first placed in culture (see above), and were
hence scored as alive, were utilized for experiments. For 10-day
experiments, any APR(6)s that were missing, were necrotic, or
failed to adhere to the dish by day 3 were excluded from the study.
The number of APR(6)s excluded on day 3 was 52 of 242 (21%). In
all experiments, except for TTFA treatment (Fig. 3), the identity of
the culture medium remained coded until after all scoring of
APR(6) phenotypes by a blind observer was completed. Throughout
each experiment and at the end of the culture period, the number
of APR(6)s that were shrunken (a quantitative marker of APR(6)
death in vivo or in vitro; Hoffman and Weeks, 1998a) was counted
under phase-contrast optics. At the end of the culture period, most
APR(6)s were incubated for 40 min in 3-(4,5-dimethylthiazol-2-yl)-
2,5-diphenyltetrazolium bromide (MTT; Sigma; 50 mg/ml, in basal
edium, at 26°C); MTT is reduced during mitochondrial respira-
ion (Slater et al., 1963; Berridge and Tan, 1993), generating a dark
Copyright © 2000 by Academic Press. All righteaction product that indicates cell viability. The color of MTT-
tained APRs was scored under bright-field optics immediately
fter the incubation period; colorless or pale pink APRs were scored
s MTT-negative while purple, blue, or black APRs were scored as
TT-positive (Hoffman and Weeks, 1998a). Some APR(6)s were
tained with rhodamine 123 (R123; 100 ng/ml; Molecular Probes),
n indicator of mitochondrial transmembrane potential (DCm;
hen, 1988). APR(6)s were incubated in R123 at room temperature
or 10 min, rinsed several times with culture medium, and viewed
nder fluorescein optics. Neurons with bright fluorescence were
cored as R123-positive (indicating negative DCm) and those with
dim or no fluorescence were scored as R123-negative (indicating
reduction or loss of DCm). In another experiment, neurons were
reated with the mitochondrial electron transfer inhibitor, TTFA,
nd observed under phase-contrast optics. Cultured APR(6)s were
hotographed on a Zeiss Axiovert 135 microscope.
Data Analysis
Data were displayed and analyzed as in a previous study (Hoff-
man and Weeks, 1998a). In some experiments with parallel experi-
mental and control cultures, the percentage of APRs exhibiting a
particular phenotype (e.g., shrunken cell body) in the experimental
group was divided by the percentage of APRs exhibiting the same
phenotype in the control group. This ratio was converted to a
percentage, 100% was subtracted, and the remainder was expressed
as percentage difference from control. For example, a difference
from control of 100% meant that twice as many experimental
APRs exhibited the phenotype as control APRs, and a difference of
250% meant that half as many experimental APRs exhibited the
phenotype as did control APRs. All statistical comparisons were
performed on raw data, by comparing the proportions of APRs
exhibiting particular phenotypes in different groups by x2 analysis
(Glass and Hopkins, 1996). Significance was assumed when P ,
.05. Mean values are presented with standard deviation.
RESULTS
Induction of PCD in APR(6)s by Actinomycin D
during the Final Larval Instar
In many cells, the proteins necessary to carry out PCD—
the “death machinery”—are present constitutively in inac-
tive form so that death can be executed without additional
protein synthesis; e.g., the protein kinase inhibitor, stauro-
sporine, can induce PCD in the presence of protein synthe-
sis blockers (Weil et al., 1996). In other cases, PCD requires
the synthesis of new proteins that are believed to activate
preexisting cell death machinery (e.g., Reaper, in Drosoph-
ila; White et al., 1994). The requirement for protein synthe-
sis may depend on where the inducing stimulus acts along
the PCD pathway; i.e., induction of PCD by a pharmaco-
logical compound may occur farther downstream in the PCD
pathway than a “natural” death-inducing stimulus and hence
bypass the need for new synthesis. The 20E-induced PCD of
APRs is inhibited by CHX both in vivo or in vitro, provided
that CHX is provided at the appropriate time (Weeks et al.,
1993; Hoffman and Weeks, 1998a); e.g., when cultured at
W3-noon, APR(6)s require both further exposure to 20E and
further protein synthesis to execute PCD, whereas when
s of reproduction in any form reserved.
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521Programmed Cell Death of a Motoneuroncultured ;24 h later, at PE, they can execute PCD without
urther exposure to 20E or further protein synthesis (Hoffman
nd Weeks, 1998a; also see Fig. 6).
We tested the hypothesis that the requirement for protein
ynthesis during the final 24 h of larval life was related to
0E being the inducing stimulus, with the prediction that a
harmacological activator of PCD could trigger death at
3-noon (or earlier) in the presence of CHX. In pilot
tudies, staurosporine did not reliably activate PCD in
ultured APR(6)s (data not shown). Accordingly, we turned
o ActD, which induces PCD in a lepidopteran cell line,
F21 (Crook et al., 1993; Cartier et al., 1994), and in some
vertebrate cells (Kluck et al., 1997). The mechanism by
which ActD induces PCD is not understood (see Discus-
sion) but this action provides a convenient pharmacological
tool. The ActD-induced PCD of SF21 cells does not require
new protein synthesis (Crook et al., 1993), consistent with
he activation of preexisting death machinery. Figure 2A
hows the protocol used to test the ability of ActD to trigger
CD of APR(6)s and the requirement for protein synthesis.
PR(6)s were placed in culture on day L2 (before the onset
f metamorphosis; see Fig. 1) or at W3-noon (the day before
upation) and maintained in control medium until day 3.
eginning on day 3, some cultures remained in control
edium while the others were switched to 100 ng/ml ActD
ith or without 10 mg/ml CHX. This concentration of ActD
triggers PCD of SF21 cells (Cartier et al., 1994) and this
concentration of CHX inhibits the 20E-induced death of
APR(6)s in vitro (see below). The ActD and ActD/CHX
cultures were done in parallel. APR(6) morphology was
scored repeatedly (mean interval between observations
1.3 6 0.6 days; n 5 261 observations) and for the final time
n day 10, when MTT staining was performed to assess
itochondrial function.
Figure 2B shows that only a small percentage of APR(6)s
ultured at W3-noon that remained in control medium
ere shrunken, and none were MTT-negative, on day 10
replicating previous findings; Hoffman and Weeks, 1998a).
n contrast, when APR(6)s cultured at W3-noon were
witched to ActD on day 3, there was a significant increase
n both the proportion that were shrunken (P , 0.005) and
he proportion that were MTT-negative (P , 0.005) on day
0, compared to APR(6)s that remained in control medium.
ctD was as effective as 20E in inducing PCD in APR(6)s
ultured at W3-noon (Hoffman and Weeks, 1998a). Cotreat-
ent with CHX during ActD exposure did not significantly
ecrease the proportion of APR(6)s cultured at W3-noon
hat were shrunken or MTT-negative on day 10, compared
o APR(6)s cultured in ActD alone (Fig. 2B). In contrast, this
oncentration of CHX decreases by ;75% the percentage of
PR(6)s cultured at W3-noon that die in response to 20E
reatment (Hoffman and Weeks, 1998a). These data support
he hypothesis that, at W3-noon, APR(6)s possess preexist-
ng death machinery that can be activated by ActD and that
xecution of PCD under these circumstances utilizes pre-
iously synthesized proteins [since CHX did not signifi-
antly decrease the proportion of dying APR(6)s]. This t
Copyright © 2000 by Academic Press. All rightontrasts with the death of the same neurons in response to
0E, which is inhibited by CHX.
Somewhat different results were obtained when APR(6)s
ere cultured 5 days earlier, on day L2. When APR(6)s
emained in control medium for 10 days, none became
hrunken and only a small percentage became MTT-
egative (Fig. 2C). When APR(6)s cultured on day L2 were
witched to ActD on day 3, there was a significant increase
n both the proportion that were shrunken (P , 0.005) and
he proportion that were MTT-negative (P , 0.05) on day
0, compared to APR(6)s that remained in control medium.
ctD was as effective in inducing the shrinkage of APR(6)s
ultured on day L2 as at W3-noon (P . 0.05; Figs. 2B and
C), whereas a significantly smaller proportion of APR(6)s
ultured on day L2 exhibited loss of MTT staining on day 10
ompared to APR(6)s cultured at W3-noon (P , 0.025; Figs.
B and 2C). APR(6)s cultured at the two different develop-
ental stages also differed in their response to CHX.
otreatment with CHX during ActD exposure significantly
educed the proportion of APR(6)s cultured on day L2 that
ere shrunken on day 10 (P , 0.01) but not the proportion
hat were MTT-negative, compared to APR(6)s cultured in
ctD alone. The former finding suggested that protein
ynthesis normally facilitates the ability of APR(6)s cul-
ured on day L2 to execute shrinkage in response to ActD.
onsistent with this possibility, the mean number of days
rom the start of ActD treatment until APR(6)s were first
cored as shrunken was 3.3 6 1.3 days for APR(6)s cultured
t W3-noon (n 5 16) and 5.2 6 1.3 days for those cultured
n day L2 (n 5 19; data not shown). This delay of ;2 days
n the onset of morphological signs of PCD in the day L2
roup is consistent with the occurrence of protein synthesis
efore death occurs (Hoffman and Weeks, 1998a). Because
oss of MTT staining generally lags cell shrinkage (K. L.
offman and J. C. Weeks, unpublished observations), this
elay may also account for the reduced proportion of
PR(6)s cultured on day L2 that were MTT-negative on day
0 (Fig. 2C), compared to those cultured at W3-noon (Fig.
B). This possibility could be tested by repeating the experi-
ent in Fig. 2C using a longer culture period.
The phenotype of APR(6)s triggered to die by ActD
cultured on day L2 or at W3-noon, in the presence or
bsence of CHX) was the same as that of APR(6)s triggered
o die by 20E (described in Streichert et al., 1997; Hoffman
nd Weeks, 1998a; also see Figs. 4C and 5C). Figures 2D and
E show a representative APR(6) cultured at W3-noon that
as switched to ActD-containing medium on day 3. On day
, the soma was large and ovoid and there was an extensive
euritic arbor with active lamellipodia and growth cones.
y day 7, the neuritic processes had fragmented and the
oma was shrunken and rounded. When MTT staining was
erformed on day 10, this APR(6) was MTT-negative (not
hown). These attributes of PCD contrast with those of
ecrotic cell death, which is marked by acute swelling and
oss of homeostatic control (Wyllie et al., 1980; Clarke,
990; Pang and Geddes, 1997). As an additional confirma-
ion that the death of APR(6)s induced by 20E or ActD was
s of reproduction in any form reserved.
522 Hoffman and WeeksFIG. 2. Induction of programmed cell death of APR(6) by actinomycin D. (A) Experimental protocol. APR(6)s were placed in culture on day L2
or at W3-noon in control medium. On day 3, some cultures remained in control medium while others were switched to medium with 100 ng/ml
ActD (ActD) or 100 ng/ml ActD plus 10 mg/ml CHX (ActD/CHX). ActD and ActD/CHX cultures were plated in parallel. Cell body morphology
(normal vs shrunken) and MTT staining (positive vs negative) were scored on day 10. The histograms in (B) and (C) show the percentage of APR(6)s
cultured at W3-noon or on day L2, respectively, that were shrunken or MTT-negative (i.e., lacked mitochondrial function) on day 10 in the
indicated culture medium. The number of APR(6)s in each group is shown above each bar. (B) ActD caused a significant increase in the proportion
of APR(6)s cultured at W3-noon that were shrunken or MTT-negative on day 10, compared to APR(6)s in control medium (**P , 0.005).
Cotreatment with CHX and ActD did not significantly affect the proportion of APR(6)s that were shrunken or MTT-negative on day 10, compared
to APR(6)s cultured in ActD alone. (C) ActD caused a significant increase in the proportion of APR(6)s cultured on day L2 that were shrunken
or MTT-negative on day 10, compared to APR(6)s in control medium (**P , 0.005; *P , 0.05). Cotreatment with CHX and ActD caused a
significant decrease in the proportion of APR(6)s that were shrunken on day 10, compared to APR(6)s cultured in ActD alone (*P , 0.01), but had
no significant effect on the proportion of APR(6)s that were MTT-negative on day 10, compared to APR(6)s cultured in ActD alone. (D, E)
Phase-contrast photomicrographs of an APR(6) cultured at W3-noon, taken on day 3 (when culture was switched to ActD) and again on day 7 of
culture. Large arrows point to the cell body; small arrows point to intact processes in (D) and fragments of the same processes in (E). When stained
on day 10, this APR(6) was MTT-negative (not shown).
Copyright © 2000 by Academic Press. All rights of reproduction in any form reserved.
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523Programmed Cell Death of a MotoneuronPCD, we used an inhibitor of mitochondrial electron trans-
fer, TTFA (Ingeldew and Ohnishi, 1977), to induce necrotic
cell death. In experiments using unidentified Manduca
neurons, we found that TTFA triggered rapid swelling and
lysis, determined the dose–response relationship for TTFA-
induced death, and confirmed that TTFA-treated neurons
lost mitochondrial function as revealed by staining with
MTT or R123 (see below; Hoffman, 1999). Neurons in
parallel cultures treated with the ethanol vehicle alone
survived at normal levels. A subset of these observations
was replicated in APR(6)s. Figure 3 shows an APR(6) cul-
tured at W3-noon that was maintained in control medium
for 4 days, when it was switched to medium containing 1.0
mM TTFA. By 2 h after TTFA treatment, the soma was
swollen and the neurites were blebby. By 24 h the soma had
ruptured. The same results were obtained with three addi-
tional APR(6)s (data not shown). The death of APR(6)s
triggered by TTFA thus differed markedly from that trig-
gered by 20E or ActD in two ways. First, the soma swelled
and ruptured (Fig. 3) rather than shrinking and persisting in
the shrunken state (Figs. 2E, 4C, and 5C; Hoffman and
Weeks, 1998a). Second, the latency to initial morphological
changes during TTFA-induced necrotic death of APR(6)s
was hours (Fig. 3) rather than the $3 days required for
ActD-induced death (see above) or $5 days required for
20E-induced death (Streichert et al., 1997; Hoffman and
Weeks, 1998a).
In summary, the readiness of APR(6)s to execute PCD in
response to ActD is greater at W3-noon than on day L2.
CHX reduces the ability to undergo ActD-induced PCD in
FIG. 3. Morphology of necrotic cell death of APR(6). Phase-contra
of the mitochondrial electron transfer inhibitor TTFA (1.0 mM) to
treated with TTFA on day 4 of culture. Arrows point to the cell bo
to neurites (which were intact at 0 h and fragmented at 2 and 24 hAPR(6)s cultured on day L2, but not at W3-noon. In APR(6)s
Copyright © 2000 by Academic Press. All rightultured on day L2, the increased latency to shrinkage,
ecreased loss of MTT staining on day 10, and ability of
HX to decrease the proportion of shrunken cells, com-
ared to APR(6)s cultured W3-noon, suggest that the readi-
ess of the death machinery increases between day L2 and
3-noon.
Effects of Caspase Inhibitor on 20E-Induced PCD
of APR(6)s Cultured at W3-Noon
Caspases (a family of cysteine proteases) are important
components of the death machinery in many vertebrates
and invertebrates (reviewed by Thornberry and Lazebnik,
1998), including Drosophila (reviewed by Abrams, 1999; see
Discussion) and the lepidopteran Spodoptera frugiperda
(Ahmad et al., 1997). Caspases have a unique requirement
for an aspartate residue at the site of proteolytic cleavage;
specific pharmacological inhibitors of caspases contain ei-
ther a single aspartate or an aspartate within a short peptide
sequence (Livingston, 1997). Caspases are synthesized as
inactive proenzymes that are proteolytically processed at
internal aspartate residues to produce the active form,
which acts on its precursor form and other substrates,
including cytoskeletal-associated proteins, DNA repair en-
zymes, and nuclear lamins (Cohen, 1997; Nicholson and
Thornberry, 1997). The autocatalytic processing of caspases
amplifies their activity. Caspase inhibitors block PCD in
both insect and mammalian cells (Clem and Miller, 1994;
Milligan et al., 1995; White et al., 1996; Kondo et al., 1997).
Figure 4A shows the protocol used to test whether
otomicrographs show an APR(6) at 0, 2, and 24 h after the addition
ulture medium. The APR(6) was placed in culture at W3-noon and
hich was swollen at 2 h and had lysed by 24 h); arrowheads pointst ph
the c
dy (wZ-Asp-CH2DCB, a broad-spectrum caspase inhibitor con-
s of reproduction in any form reserved.
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524 Hoffman and WeeksFIG. 4. Z-Asp-CH2DCB prevented 20E-induced shrinkage and loss of mitochondrial function in APR(6)s cultured at W3-noon. (A)
xperimental protocol. APR(6)s were cultured at W3-noon in medium with 1.0 mg/ml 20E. On day 3, the medium was changed to either
xperimental medium containing 1.0 mg/ml 20E and Z-Asp-CH2DCB (2.0 or 20 mM) or control medium containing only 1.0 mg/ml 20E. Cell
orphology and MTT staining were scored on day 10. (B) In the histogram, results from experimental cultures are expressed as percentages
f results obtained in parallel control cultures. The number of APR(6)s in experimental groups is shown above each bar; the number of
PR(6)s in control groups ranged from 13 to 21. Treatment with 20 mM Z-Asp-CH2DCB significantly decreased the proportion of APR(6)s
that became shrunken or MTT-negative during the 10-day culture period (*P , 0.005), whereas 2.0 mM Z-Asp-CH2DCB was ineffective.
C) Phase-contrast photomicrograph of an APR(6) cultured in 20E alone, on day 10; the cell body was rounded and shrunken (large arrow)
nd the processes were fragmented (small arrow). (D) Phase-contrast photomicrograph of an APR(6) cultured in 1.0 mg/ml 20E and 20 mM
Z-Asp-CH2DCB, on day 10; the cell body was large and ovoid (large arrow) and its processes were intact (small arrow). (E, F, G) APR(6)s
pared from PCD had functional mitochondria. APR(6)s were stained with two independent markers of mitochondrial function, R123 and
TT. A representative APR(6) cultured in 1.0 mg/ml 20E and 20 mM Z-Asp-CH2DCB is shown on day 10, in (E) phase-contrast optics (note
large, ovoid soma surrounded by lamellipodia and neurites), (F) epifluorescence optics (green indicates R123 signal), and (G) bright-field
optics (purple indicates positive MTT staining).
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525Programmed Cell Death of a Motoneurontaining a single aspartate residue (Dolle et al., 1994), inhib-
ited the 20E-induced PCD of APR(6)s. APR(6)s were placed
in culture at W3-noon in medium containing 1.0 mg/ml
20E; at this developmental stage, 20E must be provided to
trigger PCD (Hoffman and Weeks, 1998a). Beginning on day
3, control cultures remained in 1.0 mg/ml 20E while parallel
experimental cultures were switched to medium contain-
ing 1.0 mg/ml 20E plus either 2.0 or 20 mM Z-Asp-CH2DCB.
Z-Asp-CH2DCB and related single-aspartate inhibitors pro-
ect cells from death at 10–30 mM (Deshmukh et al., 1996;
arada and Sugimoto, 1998). Caspase inhibitor was added
n day 3 because the 20E-induced PCD of APR(6)s cultured
t W3-noon begins 5 days after the onset of 20E exposure
nd is blocked by adding CHX beginning on day 3 (Hoffman
nd Weeks, 1998a); thus, on day 3, APR(6)s are not yet
ommitted to die. APR(6) morphology was scored regularly
mean interval between observations 1.6 6 0.8 days; n 5
54 observations) and for the final time on day 10, when
FIG. 5. Z-Asp-CH2DCB prevented shrinkage, but not loss of mitoc
PR(6)s were cultured at PE in hormone-free medium containing 0
arallel cultures with no inhibitor. Cell morphology and MTT stain
xperimental cultures are expressed as percentages of results obtain
roups is shown above each bar; the number of APR(6)s in co
Z-Asp-CH2DCB significantly decreased the proportion of cells w
-Asp-CH2DCB at any of the three concentrations did not significa
s assessed by MTT staining. Values for control APR(6)s were the
8% were shrunken (n 5 99) and 53% were MTT-negative (n 5 75
ultured in control medium (left) and in 20 mM Z-Asp-CH2DCB (rTT staining was performed.
Copyright © 2000 by Academic Press. All rightFigure 4B presents data on APR(6) morphology and MTT
taining, with the results in experimental cultures ex-
ressed as a percentage difference from the parallel control
ultures (see Materials and Methods; Hoffman and Weeks,
998a). Cotreatment with 20 mM Z-Asp-CH2DCB during
0E exposure significantly reduced the proportion of
PR(6)s that were shrunken (P , 0.005) or MTT-negative
P , 0.005) on day 10. Treatment with the lower concen-
ration of Z-Asp-CH2DCB (2 mM) had no significant effect.
igure 4C shows an APR(6) cultured in 20E for 10 days, by
hich time its neuritic processes had fragmented, the soma
as shrunken and rounded, and MTT staining was negative
not shown). This is the expected result under these culture
onditions (Hoffman and Weeks, 1998a). In contrast, a
ifferent APR(6) in a parallel culture treated with 20E plus
0 mM Z-Asp-CH2DCB still had normal morphology on day
0 (Fig. 4D) and was MTT-positive (not shown). Thus,
-Asp-CH2DCB spared APR(6)s from 20E-induced PCD.
rial function, in APR(6)s cultured at PE. (A) Experimental protocol.
.0, or 20 mm Z-Asp-CH2DCB (experimental cultures) or in control,
were scored after 24 h in culture. (B) In the histogram, results from
parallel control cultures. The number of APR(6)s in experimental
groups ranged from 16 to 31. Treatment with 2.0 or 20 mM
shrunken morphology (*P , 0.02). In contrast, treatment with
reduce the proportion of APR(6)s that lost mitochondrial function,
as in a previous study (Hoffman and Weeks, 1998a; see Results):
4 h. (C) Phase-contrast photomicrographs of representative APR(6)s
. Both APR(6)s were MTT-negative (not shown).hond
.2, 2
ing
ed in
ntrol
ith a
ntly
same
) at 2As described below, the ability of Z-Asp-CH2DCB to
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526 Hoffman and Weeksblock the loss of MTT staining in APR(6)s is lost by PE.
Because of the importance of correctly assessing mitochon-
drial status, we tested the validity of MTT as a mitochon-
drial indicator in two independent ways. The reduction of
MTT to its insoluble purple product can occur both via
mitochondrial dehydrogenases and at extramitochondrial
sites in endosomes and cytoplasm (Berridge and Tan, 1993;
Liu et al., 1997). To test specifically the role of mitochon-
drial enzymes in MTT reduction, unidentified Manduca
neurons (n 5 278) were treated with TTFA (0 to 0.5 mM)
or 55 min and stained with MTT and/or R123; R123
ccumulates in respiring mitochondria due to negative DCm
and hence reflects a different aspect of mitochondrial func-
tion than does MTT. TTFA caused a significant, dose-
dependent increase in the proportion of neurons that be-
came MTT- or R123-negative; furthermore, within
individual neurons, the loss of MTT staining and loss of
R123 staining was well correlated (Hoffman, 1999). These
data support the assumption that mitochondria represent the
major site of MTT reduction in Manduca neurons and vali-
date MTT as an indicator of mitochondrial function. In a
second series of experiments, we used R123 as an indicator of
mitochondrial function in APR(6)s cultured in 20E and 20 mM
-Asp-CH2DCB (same protocol as Fig. 4A). On day 10, 100%
(n 5 27) of the APR(6)s were R123-positive (Hoffman, 1999),
replicating the finding in Fig. 4B that Z-Asp-CH2DCB spares
he loss of mitochondrial function normally triggered by 20E.
subset of these APR(6)s (n 5 15) was also stained with MTT
n day 10, and 80% were MTT-positive as well as R123-
ositive (Hoffman, 1999). The photomicrographs in Figs.
E–4G show a representative APR(6) that was cultured in 20E
nd 20 mM Z-Asp-CH2DCB and stained with R123 and MTT
n day 10. The soma was large and intact (Fig. 4E) and was
ositive for both R123 (Fig. 4F) and MTT (Fig. 4G). These
esults confirmed that treatment with 20 mM Z-Asp-CH2DCB
blocked the loss of mitochondrial function in APR(6)s cul-
tured at W3-noon that would otherwise have occurred in
response to 20E.
In summary, these data suggest that during the 20E-
induced PCD of APR(6)s cultured at W3-noon, both cell
body shrinkage and the loss of mitochondrial function are
caspase dependent.
Effects of Caspase Inhibitor on PCD on APR(6)s
Cultured at PE
At stage PE, which occurs ;24 h after stage W3-noon,
APR(6)s have normal morphology and are MTT-positive
(Hoffman and Weeks, 1998a). However, when placed in
culture at PE, 40–50% of APR(6)s are competent to execute
PCD (manifested by cell body shrinkage and loss of MTT
staining) over the next 24 h without the requirement for
further 20E exposure or further protein synthesis (see be-
low; Hoffman and Weeks, 1998a). It is important to note the
different minimum latencies to death in APR(6)s cultured
at W3-noon in 20E ($5 days) versus APR(6)s cultured at PE
(#1 days). The longer survival of APR(6)s cultured at
Copyright © 2000 by Academic Press. All right3-noon is explained by the required period of 20E-induced
rotein synthesis before death can occur; in contrast,
PR(6)s cultured at PE have completed the required syn-
hetic events and are poised to rapidly execute PCD (Hoff-
an and Weeks, 1998a). Although the 20E exposure be-
ween W3-noon and PE in vivo is relatively modest (Fig. 1),
he ability of 20E to induce developmental events is based
n the duration of exposure above a certain threshold
oncentration (Weeks et al., 1992). Therefore, the impor-
ance of 20E exposure during the final 24 h of larval life is
ot unexpected. The death of APR(6)s cultured at W3-noon,
ut not at PE, occurs more slowly in vitro than in vivo,
erhaps because synthetic events may be slower in culture
discussed in Streichert et al., 1997; Hoffman and Weeks,
998a).
The protocol in Fig. 5A was used to test whether Z-Asp-
H2DCB inhibited the shrinkage and loss of MTT staining
n APR(6)s cultured at PE. APR(6)s were placed in culture at
E in hormone-free medium without Z-Asp-CH2DCB (con-
trol cultures) or with 0.2, 2.0 or 20 mM Z-Asp-CH2DCB
(experimental cultures). After 24 h, cell body morphology
and MTT staining were scored, with the results in experi-
mental cultures expressed as a percentage difference from
the parallel control cultures. Treatment with 2.0 or 20 mM
Z-Asp-CH2DCB significantly reduced the proportion of
PR(6)s that were shrunken at 24 h (P , 0.02), whereas 0.2
mM Z-Asp-CH2DCB was ineffective (Fig. 5B). Figure 5C
shows an APR(6) that was cultured under control condi-
tions, which was shrunken and rounded at 24 h, and an
APR(6) that was cultured with 20 mM Z-Asp-CH2DCB and
retained normal morphology. The finding that Z-Asp-
CH2DCB inhibited the shrinkage of APR(6)s cultured at PE
uggests that this morphological change is caspase depen-
ent.
In striking contrast, treatment of APR(6)s cultured at PE
ith Z-Asp-CH2DCB did not significantly reduce the pro-
portion that were MTT-negative at 24 h (Fig. 5B); the two
highest concentrations of Z-Asp-CH2DCB (2.0 and 20 mM),
hich failed to significantly inhibit the loss of MTT stain-
ng, were nevertheless effective in inhibiting cell body
hrinkage. The failure of Z-Asp-CH2DCB to inhibit the loss
of mitochondrial function in APR(6)s cultured at PE was
replicated in another experiment (see Fig. 6B). In the experi-
mental group, many APR(6)s that had normal cell body
morphology were MTT-negative, including the Z-Asp-
CH2DCB-treated APR(6) in Fig. 6C (MTT staining not
hown).
In summary, the ability of Z-Asp-CH2DCB to inhibit the
oss of mitochondrial function in APR(6)s is lost over the
4-h period between W3-noon and PE. Furthermore, the
nding that treatment of APR(6)s cultured at W3-noon with
-Asp-CH2DCB blocks loss of MTT staining (Fig. 4B) sug-
gests that the events that commit mitochondria to their
demise are Z-Asp-CH2DCB-sensitive and hence involve
caspases. The sequential involvement of caspase activity
up- and downstream of mitochondrial events in the PCD
s of reproduction in any form reserved.
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527Programmed Cell Death of a Motoneuronpathway is observed in many cell types (see Discussion;
Green and Kroemer, 1998; Susin et al., 1998).
Comparison of Effects of CHX and Caspase
Inhibitor on PCD of APR(6)s Cultured at PE
The existing evidence supports a model in which 20E-
induced protein synthesis during the prepupal peak of
ecdysteroids (Weeks et al., 1993; Hoffman and Weeks,
1998a) is required to activate a cell death program that
involves one or more caspases (Figs. 4 and 5); once APR(6)s
are committed to PCD, events can proceed independent of
20E and new protein synthesis. This model predicts that,
for the population of APR(6)s cultured at PE that are
committed to execute PCD, it should be possible to block
death with agents that inhibit downstream effectors of PCD
(e.g., caspases) but not with protein synthesis inhibitors. We
showed previously that, in the population of APR(6)s cul-
tured at PE that will die over the next 24 h, CHX does not
prevent shrinkage or loss of mitochondrial function (Hoff-
man and Weeks, 1998a). Figure 5 showed that Z-Asp-
CH2DCB prevents shrinkage but not loss of mitochondrial
unction in this population of APR(6)s. However, because
hese results with CHX and Z-Asp-CH2DCB were obtained
n independent experiments, it was important to repeat the
xperiments in parallel cultures.
As shown in Fig. 6A, APR(6)s were cultured at PE in
ormone-free medium containing either 10 mg/ml CHX
r 20 mM Z-Asp-CH2DCB; this concentration of CHX
ignificantly inhibits shrinkage and loss of MTT staining
n APR(6)s cultured at W3-noon, but not at PE (Hoffman
nd Weeks, 1998a), and this concentration of Z-Asp-
FIG. 6. Z-Asp-CH2DCB, but not CHX, prevented shrinkage of AP
at PE in hormone-free medium with 20 mM Z-Asp-CH2DCB or in pa
ere scored after 24 h in culture. (B) The proportion of APR(6)s with
-Asp-CH2DCB compared to those treated with CHX (*P , 0.05
between the two groups. The number of APR(6)s in each group isH2DCB significantly inhibits shrinkage but not loss of A
Copyright © 2000 by Academic Press. All rightMTT staining in APR(6)s cultured at PE (Fig. 5). After
24 h of culture, the morphology of APR(6)s was scored
and they were stained with MTT. Hoffman and Weeks
(1998a) showed previously that, among APR(6)s cultured
at PE in control medium, 46% were shrunken and 50%
were MTT-negative after 24 h in culture [n . 100
APR(6)s per group; also see Fig. 5 legend]. Similar results
were obtained for the APR(6)s cultured at PE in the
presence of 10 mg/ml CHX in the present experiment:
43% were shrunken and 54% were MTT-negative after
24 h (Fig. 6B). The finding that CHX did not inhibit cell
body shrinkage or loss of MTT staining in APR(6)s
cultured at PE replicates the findings of Hoffman and
Weeks (1998a).
In contrast, treatment with 20 mM Z-Asp-CH2DCB sig-
nificantly reduced the proportion of APR(6)s that were
shrunken after 24 h in culture, compared to APR(6)s that
were cultured in CHX (P , 0.05; Fig. 6B). The ability of
-Asp-CH2DCB to inhibit shrinkage in APR(6)s cultured at
E replicates the findings in Fig. 5B. These data suggest
hat, at PE, the protein synthetic events required for cell
ody shrinkage have been completed, but that the caspase
ctivity involved in cell shrinkage can still be prevented.
mportantly, the proportion of APR(6)s cultured at PE that
ere MTT-negative at 24 h did not differ significantly
etween the CHX and the Z-Asp-CH2DCB cultures (Fig.
B), with the latter finding replicating the results in Fig. 5B.
hese data suggest that, at PE, mitochondria are already
ommitted to lose function such that neither CHX nor
-Asp-CH2DCB can rescue them. These findings support a
pecific temporal sequence of events during the PCD of
cultured at PE. (A) Experimental protocol. APR(6)s were cultured
l cultures with 10 mg/ml CHX. Cell morphology and MTT staining
nken morphology was significantly lower in cultures treated with
e proportion of MTT-negative APR(6)s did not differ significantly
n above each bar.R(6)s
ralle
shru
). ThPR(6)s (see Discussion).
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528 Hoffman and WeeksEffects of a Caspase Inhibitor on ActD-induced
PCD of APR(6)s Cultured at W3-Noon
As shown in Fig. 2, treatment of APR(6)s cultured at
W3-noon with ActD induces PCD even in the presence of
CHX, suggesting that the death machinery is already
present in the motoneurons at this time. Having identified
caspases as effectors of cell body shrinkage and loss of
mitochondrial function during the 20E-induced PCD of
APR(6)s (Fig. 4), we tested whether this was likewise the
case for PCD induced by ActD in the presence of CHX.
Figure 7A shows the experimental protocol. APR(6)s were
placed in culture at W3-noon and maintained in control
medium until day 3. Beginning on day 3, the medium was
changed to either ActD/CHX alone (same treatment as in
Fig. 2) or ActD/CHX plus 20 mM Z-Asp-CH2DCB. APR(6)
morphology was scored repeatedly (mean interval between
observations 1.3 6 0.5 days; n 5 61 observations) and for
the final time on day 10, when MTT staining was per-
formed. Figure 7B presents data on APR(6) morphology and
MTT staining, with the results in experimental cultures
expressed as a percentage difference from the parallel con-
trol cultures. Cotreatment with Z-Asp-CH2DCB during
ActD/CHX exposure significantly reduced the proportion of
APR(6)s that were shrunken on day 10 (P , 0.005) but not
he proportion of APR(6)s that were MTT-negative. The
nding that Z-Asp-CH2DCB inhibited cell body shrinkage
but not loss of mitochondrial function suggested that,
during ActD-induced PCD, cell body shrinkage but not the
loss of mitochondrial function involves caspase activity
FIG. 7. Z-Asp-CH2DCB prevented shrinkage, but not loss of mito
A) Experimental protocol. APR(6)s were cultured at W3-noon witho
g/ml ActD plus 10 mg/ml CHX (ActD/CHX), and experimenta
experimental cultures were done in parallel. Cell morphology and
experimental cultures are expressed as percentages of results obtain
groups is shown above the bars; there were 15 APR(6)s in the contr
0.005), but not the loss of mitochondrial function, in APR(6)s trea(see Discussion).
Copyright © 2000 by Academic Press. All rightDISCUSSION
Experimental results in this and prior studies support a
working model of the PCD pathway in APR(6)s (Fig. 8). The
proposed pathway, which provides a framework for future
experiments, is normally initiated by the prepupal peak of
20E. This is followed by caspase activation upstream and
downstream of mitochondrial events and culminates in the
loss of mitochondrial function and shrinkage in APR(6)s.
Although not quantified in the current study, neurite frag-
mentation also accompanies APR death in vitro (Streichert
et al., 1997; Hoffman and Weeks, 1998a; Zee and Weeks,
1998; and in preparation). As indicated in Fig. 8, it is
convenient to divide the PCD pathway into premitochon-
drial, mitochondrial, and postmitochondrial phases (e.g.,
Ellerby et al., 1997; Susin et al., 1998). The following
discussion follows the general sequence of events in the
model.
Synthetic Events during PCD of APR(6)s
The prepupal peak of 20E is the normal developmental
trigger for PCD of APRs at pupation, as shown both in vivo
(Weeks et al., 1992) and in vitro (Streichert et al., 1997). 20E
acts directly on APRs to trigger the cell-autonomous,
segment-specific pattern of PCD. Consistent with this
mode of action, APR(6)s express EcRs during the prepupal
peak (see below; J. Ewer, G. Kinch, and J. C. Weeks,
unpublished data). EcRs function as ligand-gated transcrip-
drial function, in APR(6)s cultured at W3-noon in ActD and CHX.
0E. On day 3, all cultures were switched to medium containing 100
tures additionally received 20 mM Z-Asp-CH2DCB. Control and
staining were scored on day 10. (B) In the histogram, results from
parallel control cultures. The number of APR(6)s in experimental
oups. Treatment with Z-Asp-CH2DCB prevented shrinkage (*P ,
with ActD in the presence of CHX.chon
ut 2
l cul
MTT
ed in
ol grtion factors, such that activation of EcRs by 20E alters gene
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529Programmed Cell Death of a Motoneuronexpression (Gilbert et al., 1996; Jiang et al., 1997; White et
al., 1999).
We have not tested the requirement for mRNA transcrip-
tion during the 20E-induced PCD of APR(6)s, in part be-
cause of the paradoxical ability of transcriptional inhibitors
to both activate (Cartier et al., 1994; Kluck et al., 1997; Figs.
2 and 7) and prevent (Martin et al., 1988; Galli et al., 1995;
Schulz et al., 1996) PCD under different circumstances. In
the present experiments we used ActD as a pharmacologi-
cal activator of PCD and made no assumption regarding
transcriptional effects; in no case in which ActD acts as a
PCD activator is the mechanism known, and this issue is
beyond the scope of the present paper. The relationship
between ActD concentration and mRNA synthesis inhibi-
tion in Manduca neurons has not been determined. Fahr-
bach et al. (1994) showed that treatment of intact Manduca
moths or cultured nerve cords with ActD (100 ng/ml to 250
FIG. 8. Working model of the PCD pathway in PAR(6)s. The mod
egins at the top with the prepupal peak of 20E. 20E binds to EcRs
ircle) and subsequent events are shown outside the drawing of AP
o imply an absence of intervening steps; potential feedback path
locked by treatment of APR(6)s with the indicated compound;
depending on the time of treatment. The pathway is divided into pr
for further details. Abbreviations: EcR, ecdysteroid receptor; Mt, mmg/ml) inhibited the PCD of a group of motoneurons that p
Copyright © 2000 by Academic Press. All rightie after adult emergence. This result contrasts with our
nding that ActD triggers motoneuron death (Figs. 2 and 7).
t is not known whether the motoneurons studied by
ahrbach et al. (1994) respond cell autonomously to 20E and
n fact a subset of them requires a descending neural signal
lus the 20E signal to die (Fahrbach and Truman, 1987).
urthermore, motoneuron sparing was examined, at most,
2 h after the start of ActD treatment (Fahrbach et al., 1994)
o a delayed induction of PCD by ActD would not have
een noted. In the experiments in which ActD was used to
rigger PCD of APR(6)s (discussed below), the latency from
ctD treatment to cell shrinkage was ;3 to 5 days (see
esults). Further experiments would be required to test the
ossibility that ActD can provide short-term protection of
anduca motoneurons from 20E-induced PCD due to tran-
criptional inhibition, but ultimately induces PCD in the
ame motoneurons via activation of the death pathway. A
based on findings in this and previous publications. The pathway
PR(6)s to alter gene expression (the nucleus is shown as a dashed
Arrows denote the proposed sequence of events and are not meant
are omitted. T junctions indicate steps in the pathway that are
p-CH2DCB can block at two different steps along the pathway
ochondrial, mitochondrial, and postmitochondrial phases. See text
hondria; PE, pupal ecdysis; W3-noon, day W3 at 12:00 h.el is
in A
R(6).
ways
Z-As
emitossibly related observation was made by Martin et al.
s of reproduction in any form reserved.
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530 Hoffman and Weeks(1988), who found that ActD (100 ng/ml) protected sympa-
thetic neurons from PCD during the 48 h following NGF
withdrawal (when the neurons would normally have died);
however, the neurons subsequently died 2 to 3 days later,
which would not have happened in NGF.
Some cell types can undergo PCD without synthesizing
new proteins and must therefore constitutively express the
protein components, or death machinery, necessary to
execute PCD (Weil et al., 1996). However, PCD during
evelopment or metamorphosis often requires protein syn-
hesis (Burek and Oppenheim, 1996). New protein synthesis
s clearly required for the PCD of APR(6)s in response to
0E. In vivo, treatment with CHX throughout the prepupal
eak blocks the PCD of APRs (Weeks et al., 1993). In vitro,
he 20E-induced PCD of APR(6)s cultured at W3-noon is
locked by cotreatment with CHX, whereas the PCD of
PR(6)s cultured at PE is 20E-independent and protein
ynthesis-independent (Hoffman and Weeks, 1998a; Fig. 6).
hus, during the final 24 h of larval life, 20E-dependent
rotein synthesis occurs that is required for APR(6)s to
xecute PCD in response to the 20E signal.
In contrast, CHX (at a concentration that inhibits 20E-
nduced PCD; Hoffman and Weeks, 1998a) does not block
ctD-induced PCD in APR(6)s cultured at W3-noon (Fig.
A). Thus, at W3-noon, APR(6)s possess the protein com-
onents required to execute PCD, and this death machinery
an be activated by ActD without new synthesis. Although
he mechanism by which ActD activates PCD is unknown
see above), the following observations are informative.
irst, ActD appears to act downstream of protein synthetic
vents because CHX does not block its effect (Fig. 2A).
econd, the identical morphological phenotype and loss of
itochondrial function in APR(6)s triggered to die by ActD
r 20E (Figs. 2, 4C, and 5C; Streichert et al., 1997; Hoffman
and Weeks, 1998a; Zee and Weeks, 1998; and in prepara-
tion) suggest that ActD and 20E share mitochondrial and
postmitochondrial portions of the PCD pathway, including
effector caspases. Caspases participate in ActD-induced
PCD in other insect and mammalian cells as well (Cartier
et al., 1994; Barge et al., 1997). Finally, the finding that
-Asp-CH2DCB blocks cell shrinkage but not the loss of
itochondrial function of APR(6)s treated with ActD (Fig.
) suggests that, in contrast to 20E-induced PCD, activation
f the mitochondrial phase of PCD by ActD does not
nvolve caspase activity (otherwise, Z-Asp-CH2DCB could
block mitochondrial demise). These data suggest that ActD
may bypass some of the upstream events in the 20E-
induced PCD pathway but share some of the distal steps.
Compared to APR(6)s cultured at W3-noon, a smaller
proportion of those cultured 5 days earlier, on day L2,
executed PCD when treated with ActD. Cotreatment with
CHX further reduced the response (Fig. 2B). These data
suggest that protein synthetic events between day L2 and
stage W3-noon increase the readiness of APR(6)s to undergo
PCD at pupation (this period of protein synthetic activity is
not shown in Fig. 8). Possible in vivo hormonal triggers for
this protein synthesis include the fall in JH, the commit-
Copyright © 2000 by Academic Press. All rightent pulse of 20E, and the first 3 days of the prepupal peak
f 20E (Fig. 1). Further experiments would be required to
etermine when the relevant protein synthetic events occur
nd how they are triggered.
What might be the identity and function of proteins
nvolved in the PCD of APR(6)s? Our data suggest that
ome PCD-related proteins are synthesized between day L2
nd W3-noon to increase the readiness to die, whereas
thers are synthesized in response to prepupal 20E when it
s time for APR(6) to die. Numerous candidate genes and
roteins are known in Drosophila. At the top of the PCD
athway is EcR and its heterodimerization partner, USP
Asahina et al., 1997). Immunocytochemical staining for
the two Manduca receptor isoforms, EcR-A and EcR-B1
Jindra et al., 1996), shows a substantial upregulation of EcR
rotein levels in APR(6)s between day L2 and day W1 (J.
wer, G. Kinch, and J. C. Weeks, unpublished data).
anduca motoneurons typically show this increase in EcR
evels followed by a decline during the later prepupal period
Fahrbach, 1992). The upregulation of EcR levels presum-
bly facilitates the response to 20E during the prepupal
eak. Continuing along the PCD pathway, candidate pro-
eins include chaperones or cofactors required for EcR/USP
unction (Tsai et al., 1999; Arbeitman and Hogness, 2000),
arious members of the 20E-induced transcription cascade
reviewed by Thummel, 1997), cell death activators (Dro-
ophila Reaper, Grim, or Hid; White et al., 1994; Grether et
l., 1995; Chen et al., 1996), and putative apical caspases
Dredd, Chen et al., 1998; DRONC, Dorstyn et al., 1999a).
Increased expression of rpr, hid, and dronc, and decreased
xpression of diap2 (a survival-promoting gene), in doomed
arval tissues of Drosophila is regulated by prepupal 20E
Dorstyn et al., 1999a). Likewise, 20E regulates the in-
reased expression of rpr and grim in Drosophila neurons
ated to die after adult eclosion (Robinow et al., 1997).
ther activators or modulators of PCD include hTid-1L and
Tid-1S (mitochondrial proteins that modulate cytochrome
c release and effector caspase activation; Syken et al., 1999),
Scythe (a Xenopus protein that, upon binding to Reaper,
eleases a sequestered cytochrome c-releasing factor;
Thress et al., 1998, 1999), proapoptotic members of the
Bcl-2/Bax family (Dbok, Zhang et al., 2000; Debcl, Colussi
et al., 2000; Drob-1, Igaki et al., 2000), and cytosolic
proteins required to activate effector caspases (Dapaf-1,
Dark, and HAC-1, Kanuka et al., 1999; Rodriguez et al.,
1999; Zhou et al., 1999). There are several putative effector
caspases in Drosophila (drICE, Fraser and Evan, 1997;
DCP-1, Song et al., 1997; DECAY, Dorstyn et al., 1999b). In
addition to upregulation of death-promoting proteins, the
PCD of APR(6)s could also involve the downregulation of
cell-survival-promoting proteins such Drosophila inhibitor
of apoptosis 1 (DIAP1), which inhibits caspase activation
(Kaiser et al., 1998; Meier et al., 2000).
One possibility is that proteins synthesized between day
L2 and W3-noon are components of the death machinery
such as effector caspases. Protein synthesis during the
prepupal peak, including the final 24 h of larval life when
s of reproduction in any form reserved.
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531Programmed Cell Death of a MotoneuronAPR(6)s require further 20E exposure and protein synthesis
in order to execute PCD, could involve death activators
such as Reaper. By PE, no further protein synthesis is
required and the execution phase of PCD is initiated soon
after.
The different involvement of protein synthesis during
20E- versus ActD-induced PCD in APR(6)s cultured at
W3-noon demonstrates that the nature of the inducing
stimulus is highly relevant when studying developmental
PCD. The finding that cells can undergo PCD without new
protein synthesis in response to a pharmacological activator
(e.g., staurosporine; Weil et al., 1996) does not mean that
their death in response to a normal developmental signal
will likewise be protein synthesis-independent. This issue
is difficult to address in many cell types because the normal
developmental cue for PCD is unknown, requiring the use
of pharmacological activators or the withdrawal of condi-
tioned or high-potassium medium to trigger PCD. An
advantage of working with APR(6)s is that the normal
developmental cue for PCD is known and is readily ma-
nipulated in vivo and in vitro.
Role of Caspases in the PCD of APR(6)
Caspases, a class of cysteine proteases, are a conserved
aspect of most PCD pathways (Vaux and Korsmeyer, 1999).
Caspases have an absolute requirement for an aspartate
residue at the site of substrate cleavage. The amino acids
adjacent to the aspartate confer substrate–enzyme selectiv-
ity, with different caspase family members cleaving at
distinct peptide sequences (Miller et al., 1997). In the
resent experiments we used the broad-spectrum caspase
nhibitor, Z-Asp-CH2DCB. Like other cysteine protease
inhibitors, Z-Asp-CH2DCB reacts irreversibly with cysteine
esidues in the active site of the protease (Robinson et al.,
992; Livingston, 1997) and prevents interaction with the
ative substrate. Because Z-Asp-Ch2DCB contains a single
aspartate with no adjacent amino acids, it is not selective
for specific members of the caspase family. It is also
relatively unreactive with other classes of cysteine pro-
teases (Dolle et al., 1994).
As discussed above, APR(6)s cultured at W3-noon require
urther exposure to 20E and further protein synthesis to
ndergo PCD and are not yet committed to die, whereas a
ubstantial subset of APR(6)s cultured at PE are committed
o PCD and about to initiate execution. Treatment of
PR(6)s at these two stages with Z-Asp-CH2DCB produced
trikingly different effects, strongly suggesting that there
re two sequential steps of caspase activation in the PCD
athway (Fig. 8). In APR(6)s cultured at W3-noon, 20E
reatment produces cell body shrinkage, neurite fragmenta-
ion, and loss of mitochondrial function (Hoffman and
eeks, 1998a; Fig. 4C). Cotreatment with Z-Asp-CH2DCB
roduced dose-dependent inhibition of both cell shrinkage
nd loss of mitochondrial function, as assessed by MTT
taining [Figs. 4B, 4D, 4E, and 4G; neurite fragmentation
as also prevented (Fig. 4D) but not quantified]. The pres- d
Copyright © 2000 by Academic Press. All rightnce of functional mitochondria in APR(6)s cotreated with
0E and Z-Asp-CH2DCB was further confirmed by R123
taining (Fig. 4F). Treatment with 20 mM Z-Asp-CH2DCB
rovided nearly complete protection from 20E-induced
CD of APR(6)s cultured at W3-noon (Fig. 4B). These
ndings identify a caspase-dependent step in the 20E-
nduced PCD pathway that is upstream of both the com-
itment to mitochondrial demise and the execution events
hat produce cell shrinkage and fragmentation. This step is
dentified in Fig. 8 as the activation of apical caspase(s).
In contrast to the results at W3-noon, treatment of
PR(6)s cultured at PE with Z-Asp-CH2DCB produced
ose-dependent inhibition of cell shrinkage but did not
revent the loss of mitochondrial function (Figs. 5B and 5C).
his result suggested that, for the substantial subset of
PR(6)s cultured at PE that are committed to execute PCD,
heir mitochondria are already doomed by an earlier
aspase-dependent event (see above) but that the execution
f cell shrinkage involves a separate round of caspase
ctivation that can still be inhibited by Z-Asp-CH2DCB
(Fig. 8). Time-lapse videomicroscopy of APR(6)s cultured at
PE indicate that cell shrinkage typically begins no earlier
than 6 h in culture, suggesting that the effector caspases are
activated sometime between PE and $6 h later (Weeks et
al., 2000; M. C. Zee and J. C. Weeks, unpublished observa-
tions). In the experiments with Z-Asp-CH2DCB, a concen-
tration of 2.0 mM produced effective inhibition in APR(6)s
cultured at PE (Fig. 5B) but not in those cultured at
W3-noon (Fig. 4B); one possible (but untested) explanation
for this result is if Z-Asp-CH2DCB activity declines over
time, such that 2 mM is an effective concentration over a
24-h period (the duration of the culture period at PE) but not
over a 3-day period (the number of days between medium
changes in W3-noon cultures).
Previous experiments showed that the substantial subset
of APR(6)s that are committed to PCD at PE does not
require further protein synthesis to execute death (Hoffman
and Weeks, 1998a). The proportion of APR(6)s in the
present study that had reached this state at PE (see Fig. 5
legend and Fig. 6B) was the same as in the previous study.
We replicated the finding that CHX does not significantly
inhibit cell shrinkage in APR(6)s cultured at PE and
showed, in parallel cultures, that treatment with Z-Asp-
CH2DCB was still able to prevent cell shrinkage even after
HX was no longer effective (Fig. 6B). Neither agent,
owever, significantly inhibited the loss of mitochondrial
unction when provided at PE (Fig. 6B). These data support
he sequence of events shown in Fig. 8, in which mitochon-
ria become committed to their demise prior to PE (and
herefore can no longer be spared by CHX or Z-Asp-
H2DCB) and in which APR(6)s cultured at PE are past the
equirement for protein synthesis but their cell shrinkage
an still be prevented by inhibiting effector caspase activa-
ion with Z-Asp-CH2DCB.
The effects of Z-Asp-CH2DCB on the 20E-induced PCD
f APR(6)s support premitochondrial and postmitochon-
rial phases of caspase activity, a strategy that is used
s of reproduction in any form reserved.
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532 Hoffman and Weeksduring PCD of other cell types as well (reviewed by Green
and Kroemer, 1998; Susin et al., 1998). In this scenario,
premitochondrial apical caspases trigger mitochondrial
events that lead to the activation of effector caspases. These
mitochondrial events include the induction of permeability
transition and release of PCD-triggering factors such as
cytochrome c, apoptosis-inducing factor, and procaspases,
accompanied by the loss of DCm and generation of reactive
oxygen species (Zamzami et al., 1995; Liu et al., 1996; Susin
et al., 1996, 1999a,b; Kluck et al., 1997). In addition to
triggering effector caspase activity, these mitochondrial
events may doom the mitochondria to loss of function (e.g.,
Krippner et al., 1996). This general mechanism is utilized
for a subset of Fas-mediated PCD in mammals (Scaffidi et
al., 1998) and in Reaper- and Grim-mediated PCD in a
Drosophila cell line (in the latter case cytochrome c under-
goes a conformational change rather than being released
into the cytosol; Varkey et al., 1999). As discussed above,
our data suggest that mitochondria in APR(6)s become
committed to their demise by a 20E-induced, caspase-
dependent step that occurs between stages W3-noon and
PE. The mitochondrial phase of PCD involves both the loss
of enzyme function (as revealed by MTT staining) and the
loss of DCm (as revealed by R123 staining). The latter
finding suggests that mitochondrial permeability transition
(Lemasters et al., 1998) may occur during the PCD of
APR(6)s.
With regard to the identity of apical and effector caspases,
the molecular data most relevant to Manduca come from
Drosophila. The five Drosophila caspases identified to data
can be classified by their prodomain structure and pharma-
cological properties as putative apical caspases (Dredd and
DRONC) or effector caspases (DCP-1, drICE, and DECAY;
reviewed by Abrams, 1999; Dorstyn et al., 1999b). One
caspase identified in a lepidopteran, S. frugiperda, appears
to be an effector (Ahmad et al., 1997). The induction of
Drosophila effector caspase activity by mitochondrial pro-
teins involves cytosolic cofactors (Dapaf-1, Dark, HAC-1;
Kanuka et al., 1999; Rodriguez et al., 1999; Zhou et al.,
1999). Underscoring the conservation of basic cellular
mechanisms for regulation of PCD, all of these proteins
share homologies with functionally similar proteins in
mammals.
Remaining Questions
For parsimony, this study focused on a single identified
motoneuron, APR(6). Although not tested directly, the
PCD mechanisms described here are likely to be the same
in the APR homologs located in A1 and A5, which die at
the same time as APR(6)s (Weeks and Ernst-
Utzschneider, 1989; Weeks et al., 1992). A more interest-
ing issue concerns the APRs in segments A2, A3, and A4
that survive pupation but die following adult emergence.
APR(4)s have been studied as representatives of this class
of APRs. There are no detectable differences in EcR
immunoreactivity in APR(4)s and APR(6)s during the
Copyright © 2000 by Academic Press. All rightrepupal peak (J. Ewer, G. Kinch, and J. C. Weeks,
npublished data), suggesting that EcR levels do not
etermine whether the APRs live or die. The death of
PR(4)s after adult emergence is cell autonomous and
riggered by the decline in 20E at the end of pupal life
Zee and Weeks, 1998; and in preparation). None of the
spects of the model in Fig. 8 have yet been tested in
PR(4)s, but the phenotype of PCD in APR(4)s and
PR(6)s is the same, so the same execution events may
ccur. An intriguing issue is how, in a segmental series of
omologous motoneurons, PCD is triggered in one subset
f cells by a rise in 20E at one time in development (the
arval–pupal transformation) and in another subset of
ells by a fall in 20E at a later time in development (adult
mergence). The difference may be at the level of EcR
ignaling or other early events in the pathway. Intrinsic
egmental identity regulates APRs’ responses to 20E, but
he encoding of segmental identity in APRs and its effects
n the 20E-induced gene expression remain to be deter-
ined.
Transmission electron microscopy of APR(6)s indicates
hat they die by an autophagic, not an apoptotic, process
Weeks et al., 2000; and in preparation). Apoptosis and
utophagy have different ultrastructural features and inter-
ediate phenotypes are also possible (Clarke, 1990; Jia et
l., 1997; Xue et al., 1999). During PCD in APR(6)s, there is
massive accumulation of autophagic and lamellar bodies
but no condensation of chromatin prior to nuclear fragmen-
tation (a defining feature of apoptosis). The same ultrastruc-
tural phenotype is seen in other Manduca neurons during
PCD (Stocker et al., 1978), suggesting that similar execu-
tion events occur. The APR system permits further inves-
tigation of the mechanisms by which a steroid hormone
signal activates caspase-dependent, autophagic cell death.
Most aspects of the working model in Fig. 8 should be
tested in more detail. For example, imaging of mitochon-
drial events (Wadia et al., 1998), the use of pharmacolog-
ical agents to inhibit mitochondrial permeability transi-
tion and signaling events (Zamzami et al., 1996; Bradham
et al., 1998), the use of specific inhibitors or fluorogenic
peptide substrates to test the involvement of specific
caspases (Enari et al., 1996; Kondo et al., 1997), or
single-cell characterization of gene expression (Freeman
et al., 1999) would be informative. Many details remain
to be worked out, but this model represents the most
detailed information currently available for PCD in
Manduca neurons, which have been fruitful subjects for
investigating steroid-regulated neuronal death for nearly
20 years (Truman and Schwartz, 1984). The advantages of
APRs are that they are large and can be studied both in
vivo and in vitro and, perhaps most importantly, the
normal developmental cue for their demise—prepupal
20E—is known, acts cell autonomously, and can be
readily manipulated. The precise segment-specific PCD
of APRs occurs in a well-characterized hormonal, devel-
opmental, and behavioral context (reviewed by Weeks,
1999), providing a useful system in which to investigate
s of reproduction in any form reserved.
533Programmed Cell Death of a Motoneuronhow neuronal death or survival is regulated at the level of
a single neuron and how PCD contributes to the recon-
figuration of neural circuits during development.
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